Judgment of the Court (Fourth Chamber) of 11 April 2013.   Novartis Pharma GmbH v Apozyt GmbH.   Reference for a preliminary ruling: Landgericht Hamburg - Germany.   Reference for a preliminary ruling - Regulation (EC) No 726/2004 - Medicinal products for human use - Procedure for authorisation - Requirement for authorisation - Concept of medicinal products ‘developed’ by means of certain biotechnological processes; as referred to in point 1 of the Annex to that regulation - Repackaging process - Injectable solution distributed in single-use vials containing a larger quantity of the therapeutic solution than that actually used for the purposes of medical treatment - Part of the content of such vials drawn off; on prescription by a doctor; into syringes pre-filled with the prescribed dose; without any modification of the medicinal product. 